Don't Wait and put Your Health At Risk!

>>> Ask Our Doctors Now


      Advertisements

Health Expert

Our Doctors answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question about Idarubicin? Ask Our Doctors!

Vaccine Safety

Idarubicin Side Effects

>>>Help Community - Post Your Idarubicin Side Effect

More Rx Information:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ask about Idarubicin Side Effects

Health Expert

A Health Expert wants to answer your question.

Please Provide Details below.



Idarubicin Safety Reports reported to FDA

Total Idarubicin reports: 25.
Idarubicin FDA safety alerts: No.
Reported deaths: 12    Reported hospitalizations: 14.
Take Idarubicin Side Effects Survey or Share Your Idarubicin Story.
Reported Idarubicin Side Effects: febrile neutropenia, anaemia, cardiac arrest, pain, multi-organ failure, thrombocytopenia, acute myeloid leukaemia, infection, intestinal obstruction, skin ulcer, skin graft failure.
More About Idarubicin.
If you have questions about Idarubicin, you can post them to our Doctors or Ask Patient Community about Idarubicin.

Idarubicin Side Effects Report #5251856-4
Pharmacist from UNITED KINGDOM reported IDARUBICIN problem on Feb 19, 2007. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, bone marrow failure, cardiac disorder, mucosal inflammation. IDARUBICIN dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died.

Idarubicin Side Effects Report #5253622-2
IDARUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Feb 19, 2007. Female patient, 28 years of age, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: aplasia, squamous cell carcinoma. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, FLUDARABINE PHOSPHATE, FILGRASTIM, THIOGUANINE. Patient recovered.

Idarubicin Side Effects Report #5273103-X
Consumer or non-health professional from AUSTRALIA reported IDARUBICIN problem on Mar 12, 2007. Female patient, weighting 134.5 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, PEGFILGRASTIM, GENTAMICIN, FLUCONAZOLE, VALTREX, MAXOLON. Patient died on 01/29/2007.

Idarubicin Side Effects Report #5282211-9
IDARUBICIN problem was reported by a Consumer or non-health professional from AUSTRALIA on Mar 19, 2007. Male patient, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile neutropenia. IDARUBICIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, PEGFILGRASTIM, ACYCLOVIR, FLUCONAZOLE, PANTOPRAZOLE, NYSTATIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5288994-6
Consumer or non-health professional from AUSTRALIA reported IDARUBICIN problem on Mar 28, 2007. Male patient, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile neutropenia. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, PEGFILGRASTIM, ACYCLOVIR, FLUCONAZOLE, PANTOPRAZOLE, NYSTATIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5296631-X
IDARUBICIN problem was reported by a Physician from UNITED KINGDOM on Apr 02, 2007. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, bone marrow failure, cardiac disorder, mucosal inflammation. IDARUBICIN dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died.

Idarubicin Side Effects Report #5344518-6
Consumer or non-health professional from KOREA, REPUBLIC OF reported IDARUBICIN problem on May 23, 2007. Female patient, 50 years of age, was diagnosed with acute myeloid leukaemia, ovarian epithelial cancer and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, anaemia, asthenia, renal failure acute, thrombocytopenia. IDARUBICIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, PACLITAXEL, TOPOTECAN, ENOCITABINE. Patient was hospitalized. Patient died.

Idarubicin Side Effects Report #5346697-3
IDARUBICIN problem was reported by a Health Professional from UNITED KINGDOM on May 24, 2007. Male patient, 36 years of age, was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, febrile neutropenia, multi-organ failure, neutropenic sepsis. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTOSINE ARABINOSIDE, FLUDARABINE, FILGRASTIM. Patient died on 04/23/2007.

Idarubicin Side Effects Report #5056337-9
Physician from JAPAN reported IDARUBICIN problem on July 03, 2006. Female patient, 57 years of age, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: ascites, asterixis, blood albumin decreased, blood fibrinogen decreased, coma hepatic, condition aggravated, encephalopathy, hepatic failure, hepatitis b. IDARUBICIN dosage: 18 MG (18 MG, QD), INTRAVENOUS. During the same period patient was treated with CYTARABINE, MITOXANTRONE, VANCOMYCIN HYDROCHLORIDE, ITRACONAZOLE, SULFAMETHOXAZOLE, MEROPEN, AMIKACIN SULPHATE. Patient was hospitalized and became disabled. Patient died on 12/13/2005.

Idarubicin Side Effects Report #5071665-9
IDARUBICIN problem was reported by a Health Professional from AUSTRALIA on July 19, 2006. Male patient, 27 years of age, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: anaemia, enterocolitis, eye disorder, febrile neutropenia, ileus, klebsiella sepsis, liver function test abnormal, lung consolidation. IDARUBICIN dosage: (16 MG, DAILY), INTRAVENOUS. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient recovered.

Idarubicin Side Effects Report #5087101-2
Health Professional from AUSTRALIA reported IDARUBICIN problem on Aug 07, 2006. Female patient, 51 years of age, weighting 171.3 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haemorrhoids. IDARUBICIN dosage: 17.5 MG (17.5 MG, DAILY, INTERVAL: DAYS 1-3), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE, NEUPOGEN, ACYCLOVIR, VORICONAZOLE, PANTOPRAZOLE, ACETAMINOPHEN, DOCUSATE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5102651-8
IDARUBICIN problem was reported by a Health Professional from AUSTRALIA on Aug 25, 2006. Female patient, 51 years of age, weighting 171.3 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haemorrhoids, inflammation, pain. IDARUBICIN dosage: 17.5 MG (17.5 MG, DAILY, INTERVAL: DAYS 1-3), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE, NEUPOGEN, ACYCLOVIR, VORICONAZOLE, PANTOPRAZOLE, ACETAMINOPHEN, DOCUSATE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5120517-4
Health Professional from AUSTRALIA reported IDARUBICIN problem on Sept 19, 2006. Female patient, 59 years of age, weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: agitation, atrial fibrillation, blood potassium increased, blood pressure systolic increased, bradycardia, bradypnoea, cardiac arrest, cardio-respiratory arrest, dyspnoea. IDARUBICIN dosage: (17 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE, ALLOPURINOL, TROPISETRON, LORAZEPAM, METOPROLOL, SERTRALINE, OMEPRAZOLE. Patient died on 09/15/2006.

Idarubicin Side Effects Report #5130014-8
IDARUBICIN problem was reported by a Physician from JAPAN on May 23, 2006. Female patient, 57 years of age, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: asterixis, coma hepatic, condition aggravated, encephalopathy, hepatic failure, hepatitis b, hepatitis fulminant, immunosuppression, oedema peripheral. IDARUBICIN dosage: 18 MG (18 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with CYTARABINE, MITOXANTRONE, VANCOMYCIN HYDROCHLORIDE, ITRACONAZOLE, SULFAMETHOXAZOLE, MEROPEN, AMIKACIN SULPHATE. Patient was hospitalized and became disabled. Patient died on 12/13/2005.

Idarubicin Side Effects Report #5134073-8
Health Professional from FRANCE reported IDARUBICIN problem on Sept 09, 2006. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: pain, pyoderma gangrenosum, skin graft failure, skin ulcer. IDARUBICIN dosage: 10 MG/M2, INTRAVENOUS. During the same period patient was treated with CYTARABINE, NORETHANDROLONE, MERCAPTOPURINE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5136931-7
IDARUBICIN problem was reported by a Health Professional from FRANCE on Oct 09, 2006. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: impaired healing, injury, pain, pyoderma gangrenosum, skin graft failure, skin ulcer. IDARUBICIN dosage: 10 MG/M2), INTRAVENOUS. During the same period patient was treated with CYTARABINE, NORETHANDROLONE, MERCAPTOPURINE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5192324-8
Consumer or non-health professional from AUSTRALIA reported IDARUBICIN problem on July 05, 2006. Male patient, weighting 231.5 lb, was diagnosed with acute myeloid leukaemia, colony stimulating factor prophylaxis and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, atrial fibrillation, cardiac failure congestive, febrile neutropenia, fluid overload, hypokalaemia, hyponatraemia, multi-organ failure. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, FILGRASTIM. Patient died on 07/20/2006.

Idarubicin Side Effects Report #5403209-3
IDARUBICIN problem was reported by a Consumer or non-health professional from AUSTRALIA on July 20, 2007. Female patient, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: brain hypoxia, cardiac arrest, cognitive disorder. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient recovered.

Idarubicin Side Effects Report #5407546-8
Consumer or non-health professional from AUSTRALIA reported IDARUBICIN problem on July 26, 2007. Female patient, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, TAZOCIN, PHOSPHATE, ACETAMINOPHEN, POSACONAZOLE, PANTOPRAZOL. Patient recovered.

Idarubicin Side Effects Report #5425656-6
IDARUBICIN problem was reported by a Consumer or non-health professional from on Aug 14, 2007. Female patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, intestinal obstruction. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, PALIFERMIN, PEGFILGRASTIM. Patient was hospitalized. Patient died on 08/19/2007.

Idarubicin Side Effects Report #5428099-4
Health Professional from UNITED KINGDOM reported IDARUBICIN problem on Aug 16, 2007. Male patient, 36 years of age, was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, acute myeloid leukaemia, febrile neutropenia, multi-organ failure, neutropenic sepsis. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 04/23/2007.

Idarubicin Side Effects Report #5442252-5
IDARUBICIN problem was reported by a Consumer or non-health professional from AUSTRALIA on Aug 23, 2007. Male patient, weighting 251.3 lb, was diagnosed with acute myeloid leukaemia, neutrophil count increased, stomatitis and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, infection, thrombocytopenia. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NEUPOGEN, NEULASTA, NILSTAT, CHLORHEXIDINE GLUCONATE, ITRACONAZOLE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5442261-6
Consumer or non-health professional from AUSTRALIA reported IDARUBICIN problem on Aug 23, 2007. Male patient, weighting 251.3 lb, was diagnosed with acute myeloid leukaemia, neutrophil count increased, stomatitis and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, infection, thrombocytopenia. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NEUPOGEN, NEULASTA, NILSTAT, CHLORHEXIDINE GLUCONATE, ITRACONAZOLE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5442407-X
IDARUBICIN problem was reported by a Consumer or non-health professional from AUSTRALIA on Aug 23, 2007. Female patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, intestinal obstruction. IDARUBICIN dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, PALIFERMIN, PEGFILGRASTIM. Patient was hospitalized. Patient died on 08/19/2007.

Idarubicin Side Effects Report #5449336-6
Physician from JAPAN reported IDARUBICIN problem on Aug 30, 2007. Male patient, weighting 117.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, fungal infection, sepsis, vomiting, hyperuricaemia and was treated with IDARUBICIN. After drug was administered, patient experienced the following problems/side effects: jaundice. IDARUBICIN dosage: unknown. During the same period patient was treated with VORICONAZOLE, DIFLUCAN, MAXIPIME, CYLOCIDE, NASEA, ALLOPURINOL. Patient recovered.


Ask Our Patient Community about Idarubicin

>>New! Check out useful Hospital Quality Data! Click on a state to continue:

ALABAMA
ALASKA
AMERICAN SAMOA
ARIZONA
ARKANSAS
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
DISTRICT OF COLUMBIA
FEDERATED STATES OF MICRONESIA
FLORIDA
GEORGIA
GUAM
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MAINE
MARSHALL ISLANDS
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
MONTANA
NEBRASKA
NEVADA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEW YORK
NORTH CAROLINA
NORTH DAKOTA
NORTHERN MARIANA ISLANDS
OHIO
OKLAHOMA
OREGON
PALAU
PENNSYLVANIA
PUERTO RICO
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VERMONT
VIRGIN ISLANDS
VIRGINIA
WASHINGTON
WEST VIRGINIA
WISCONSIN
WYOMING

>>NEW! Home Care Provider Quality Reports and Home Care Provider Reviews

ALABAMA
ALASKA
AMERICAN SAMOA
ARIZONA
ARKANSAS
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
DISTRICT OF COLUMBIA
FEDERATED STATES OF MICRONESIA
FLORIDA
GEORGIA
GUAM
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MAINE
MARSHALL ISLANDS
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
MONTANA
NEBRASKA
NEVADA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEW YORK
NORTH CAROLINA
NORTH DAKOTA
NORTHERN MARIANA ISLANDS
OHIO
OKLAHOMA
OREGON
PALAU
PENNSYLVANIA
PUERTO RICO
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VERMONT
VIRGIN ISLANDS
VIRGINIA
WASHINGTON
WEST VIRGINIA
WISCONSIN
WYOMING
PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about prescription drug side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding Idarubicin safety information and found answers to Your Questions about Idarubicin side effects